Oncology Focus : CAR-T and CAR-NK therapies represent ~30% of all cell and gene trials, with a strong focus on solid and hematological malignancies. Significant attention on gastrointestinal tract and ...

Phase 1: Discovery and Preclinical Phases: Identification and testing of potential drug compounds. Duration: 1 to 6 years.

Continuous research has led to new drug developments ... comprehensive global coverage of pipeline multiple sclerosis therapies in various stages of clinical development, major pharmaceutical ...